These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Level of evidence for therapeutic drug monitoring of vancomycin]. Jelassi ML, Benlmouden A, Lefeuvre S, Mainardi JL, Billaud EM, Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Therapie; 2011; 66(1):29-37. PubMed ID: 21466775 [Abstract] [Full Text] [Related]
8. Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin. Masuda N, Maiguma T, Komoto A, Haruki Y, Sugiyama T, Kondo S, Teshima D. Int J Clin Pharmacol Ther; 2015 Apr; 53(4):284-91. PubMed ID: 25740266 [Abstract] [Full Text] [Related]
14. Performance of a vancomycin dosage regimen developed for obese patients. Reynolds DC, Waite LH, Alexander DP, DeRyke CA. Am J Health Syst Pharm; 2012 Jun 01; 69(11):944-50. PubMed ID: 22610026 [Abstract] [Full Text] [Related]